LN Robotics inc. (AVIAR)

Founded in 2019, LN Robotics Inc. emerged from a medical robot research team based at Asan Medical Center that was established in 2012. Our focus has been developing cutting-edge medical robots incorporating advanced technologies like artificial intelligence, big data, robotics, and biotechnology, with significant input from clinical experts. Our vision is to provide precision medical robots that can help meet a range of unmet clinical needs. At LN Robotics, we are committed to driving innovation in the medical robotics industry by creating effective and accurate robots for various treatments. We aim to be the go-to provider of medical robots that offer enhanced patient care and deliver superior health outcomes. The AVIAR system is to help treat patients with vascular diseases. The current focus is the PCI (Percutaneous Coronary Intervention) to treat cardiovascular diseases, which are one of the top causes of death worldwide. AVIAR combines advanced technologies such as artificial intelligence, big data, robotics, and biomaterial to improve the outcome of intervention procedures and reduce radiation exposure through remote operations. We pursue beyond the limits of conventional manual techniques and better implementation of robotic intervention procedures.